Network-based integrative multi-omics approach reveals biosignatures specific to COVID-19 disease phases

Mild data-driven approach Mild hypothesis-driven approach Moderate data-driven approach Moderate hypothesis-driven approach Severe data-driven approach Severe hypothesis-driven approach